Literature DB >> 25591584

MicroRNA 363 mediated positive regulation of c-myc translation affect prostate cancer development and progress.

Y Chen, X Lu, B Wu, Y Su, J Li, H Wang.   

Abstract

UNLABELLED: Prostate cancer (CaP) is the sixth most significant cancer killer of men in China. In this study, the potential role of micro-363 (miR-363) in CaP development and progression was investigated. Pri-miR-363 or anti-miR-363 was transfected into the CaP cells line PC-3 cells. Cell proliferation, transformation property, and epithelial-to-mesenchymal transition (EMT) were evaluated by MTT, clonogenic assay, colony formation in soft agar and western blotting, respectively. The expression and involvement of c-myc, a downstream target of miR-363 were also determined. The results showed that endogenous expression of miR-363 was significantly increased in CaP cells compared with normal prostate cells. High expression of miR-363 in PC-3 cells through transfection induces cell proliferation and positively regulates cell transformation property as well as promotes EMT of PC-3 cells. Through knockdown of c-myc, the results also showed that c-myc was involved in the regulation of biological function of PC-3 cells by miR-363. Taken together, this study adds support to the potential role of miR-363 in the diagnosis and treatment of CaP. KEYWORDS: Prostate cancer, transformation property, proliferation, micro-363, epithelial-to-mesenchymal transition.

Entities:  

Year:  2015        PMID: 25591584     DOI: 10.4149/neo_2015_024

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  13 in total

1.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.

Authors:  Yuxin Lin; Xin Qi; Jing Chen; Bairong Shen
Journal:  Precis Clin Med       Date:  2022-01-10

3.  MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2.

Authors:  Xiangnan Dong; Yang Li; Rui Cao; Honglan Xu
Journal:  Biochem Genet       Date:  2021-02-25       Impact factor: 1.890

4.  MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.

Authors:  Jia Liu; Qun Li; Rui Li; Peiyou Ren; Su Dong
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 5.942

5.  MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.

Authors:  Yang Lin; Tianmin Xu; Shunqing Zhou; Manhua Cui
Journal:  Oncotarget       Date:  2017-09-30

6.  Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.

Authors:  Elnaz Pashaei; Elham Pashaei; Maryam Ahmady; Mustafa Ozen; Nizamettin Aydin
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

7.  Micro RNA-363 inhibits esophageal squamous cell carcinoma progression by directly targeting sperm-associated antigen 5.

Authors:  Lingmin Zhang; Li Wang; Ning Lu; Jia Wang; Rong Yan; Honglin Yan; Jia Zhang; Mingxin Zhang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

8.  miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1.

Authors:  Yongpeng Xie; Luyao Chen; Yu Gao; Xin Ma; Weiyang He; Yu Zhang; Fan Zhang; Yang Fan; Liangyou Gu; Pin Li; Xu Zhang; Xin Gou
Journal:  Cancer Cell Int       Date:  2020-06-10       Impact factor: 5.722

9.  miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2.

Authors:  Zeinab Mohamed; Mohamed Kamel Hassan; Safwat Okasha; Takashi Mitamura; Sarah Keshk; Yusuke Konno; Tatsuya Kato; Sherif F El-Khamisy; Yusuke Ohba; Hidemichi Watari
Journal:  Oncotarget       Date:  2018-07-10

10.  MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.

Authors:  Lanqin Cao; Qian Wan; Fengjie Li; Can-E Tang
Journal:  BMB Rep       Date:  2018-09       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.